-
2
-
-
0028208538
-
Etiology, epidemiology, risk factors, and public health issues of melanoma
-
Elwood JM, Koh HK. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol. 1994;6:179-87.
-
(1994)
Curr Opin Oncol.
, vol.6
, pp. 179-187
-
-
Elwood, J.M.1
Koh, H.K.2
-
3
-
-
0025277124
-
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease
-
Masri GD, Clark WH Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6 Pt 1):1042-8.
-
(1990)
J Am Acad Dermatol.
, vol.22
, Issue.6 PART 1
, pp. 1042-1048
-
-
Masri, G.D.1
Clark Jr., W.H.2
Guerry IV, D.3
Halpern, A.4
Thompson, C.J.5
Elder, D.E.6
-
4
-
-
0025745493
-
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study
-
Halpern AC, Guerry D 4th, Elder DE, Clark WH Jr, Synnestvedt M, Norman S, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991;127:995-9.
-
(1991)
Arch Dermatol.
, vol.127
, pp. 995-999
-
-
Halpern, A.C.1
Guerry IV, D.2
Elder, D.E.3
Clark Jr., W.H.4
Synnestvedt, M.5
Norman, S.6
-
5
-
-
0016819881
-
The developmental biology of primary human malignant melanomas
-
Clark WH Jr, Ainsworth AM, Bernardino EA, Yang CH, Mihm CM Jr, Reed RJ. The developmental biology of primary human malignant melanomas. Semin Oncol. 1975;2:83-103.
-
(1975)
Semin Oncol.
, vol.2
, pp. 83-103
-
-
Clark Jr., W.H.1
Ainsworth, A.M.2
Bernardino, E.A.3
Yang, C.H.4
Mihm Jr., C.M.5
Reed, R.J.6
-
6
-
-
0014884119
-
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
-
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-8.
-
(1970)
Ann Surg.
, vol.172
, pp. 902-908
-
-
Breslow, A.1
-
7
-
-
0018108412
-
A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods
-
Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978;188:732-42.
-
(1978)
Ann Surg.
, vol.188
, pp. 732-742
-
-
Balch, C.M.1
Murad, T.M.2
Soong, S.J.3
Ingalls, A.L.4
Halpern, N.B.5
Maddox, W.A.6
-
8
-
-
0018509979
-
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma
-
Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. 1979;86:343-51.
-
(1979)
Surgery
, vol.86
, pp. 343-351
-
-
Balch, C.M.1
Soong, S.J.2
Murad, T.M.3
Ingalls, A.L.4
Maddox, W.A.5
-
9
-
-
0020078461
-
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and metastasis
-
Day CL Jr, Mihm MC Jr, Lew RA, Harris MN, Kopf AW, Fitzpatrick TB, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and metastasis. Ann Surg. 1982;195:35-43.
-
(1982)
Ann Surg.
, vol.195
, pp. 35-43
-
-
Day Jr., C.L.1
Mihm Jr., M.C.2
Lew, R.A.3
Harris, M.N.4
Kopf, A.W.5
Fitzpatrick, T.B.6
-
10
-
-
0024814687
-
Model predicting survival in stage I melanoma based on tumor progression
-
Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893-904.
-
(1989)
J Natl Cancer Inst.
, vol.81
, pp. 1893-1904
-
-
Clark Jr., W.H.1
Elder, D.E.2
Guerry IV, D.3
Braitman, L.E.4
Trock, B.J.5
Schultz, D.6
-
11
-
-
0027237207
-
Treatment of human melanoma with a hapten-modified autologous vaccine
-
Berd D, Maguire HC Jr, Mastrangelo MJ. Treatment of human melanoma with a hapten-modified autologous vaccine. Ann N Y Acad Sci. 1993;690: 147-52.
-
(1993)
Ann N Y Acad Sci.
, vol.690
, pp. 147-152
-
-
Berd, D.1
Maguire Jr., H.C.2
Mastrangelo, M.J.3
-
12
-
-
0028205790
-
Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside
-
Livingston PO, Wong GY, Adluri S, Tao Y, Padavan M, Parente R, et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol. 1994;12:1036-44.
-
(1994)
J Clin Oncol.
, vol.12
, pp. 1036-1044
-
-
Livingston, P.O.1
Wong, G.Y.2
Adluri, S.3
Tao, Y.4
Padavan, M.5
Parente, R.6
-
13
-
-
0030030347
-
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
-
Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17.
-
(1996)
J Clin Oncol.
, vol.14
, pp. 7-17
-
-
Kirkwood, J.M.1
Strawderman, M.H.2
Ernstoff, M.S.3
Smith, T.J.4
Borden, E.C.5
Blum, R.H.6
-
16
-
-
0020083498
-
The meaning and use of the area under a receiving operating characteristic (ROC) curve
-
Hanley JA, McNeil BJ. The meaning and use of the area under a receiving operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
-
(1982)
Radiology
, vol.143
, pp. 29-36
-
-
Hanley, J.A.1
McNeil, B.J.2
-
17
-
-
0020524559
-
A method of comparing the areas under receiver operating characteristic curves derived from the same cases
-
Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148:839-43.
-
(1983)
Radiology
, vol.148
, pp. 839-843
-
-
Hanley, J.A.1
McNeil, B.J.2
|